ARCUTIS BIOTHERAPEUTICS INC's ticker is ARQT and the CUSIP is 03969K108. A total of 144 filers reported holding ARCUTIS BIOTHERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $56,859 | -44.0% | 10,708 | +0.4% | 0.00% | – |
| Q2 2023 | $101,599 | -33.9% | 10,661 | +2.7% | 0.00% | -100.0% |
| Q4 2022 | $153,609 | -23.2% | 10,379 | -0.2% | 0.00% | – |
| Q1 2022 | $200,000 | -26.5% | 10,401 | -20.8% | 0.00% | -100.0% |
| Q4 2021 | $272,000 | -20.2% | 13,127 | -8.0% | 0.00% | 0.0% |
| Q3 2021 | $341,000 | -22.9% | 14,275 | -11.9% | 0.00% | 0.0% |
| Q2 2021 | $442,000 | +16.3% | 16,197 | +23.4% | 0.00% | 0.0% |
| Q1 2021 | $380,000 | +19.5% | 13,128 | +16.0% | 0.00% | 0.0% |
| Q4 2020 | $318,000 | – | 11,319 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 8,684,232 | $46,113,272 | 3.06% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,105,309 | $5,869,191 | 2.34% |
| Bain Capital Life Sciences Investors, LLC | 3,000,000 | $15,930,000 | 1.78% |
| Sio Capital Management, LLC | 635,969 | $3,376,995 | 1.04% |
| Rubric Capital Management LP | 5,034,530 | $26,733,354 | 1.00% |
| Tejara Capital Ltd | 309,179 | $1,641,740 | 0.93% |
| AlphaCentric Advisors LLC | 165,000 | $876,150 | 0.50% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,135,227 | $6,028,055 | 0.33% |
| Orbimed Advisors | 1,914,479 | $10,165,883 | 0.22% |
| Two Seas Capital LP | 164,807 | $875,125 | 0.18% |